ZOM (zomedica.com) Aset Perusahaan

The daily price chart for Zomedica Corp. (ZOM) total assets on the GURU.Markets platform shows a value of 0.00. The business relies on alliances with distributors and laboratories to implement animal health monitoring systems. High margins are driven by the sale of consumables for TRUFORMA hormone rapid analyzers. Patent protection for these developments and the specifics of FDA certification create significant barriers to entry for competitors.

Zomedica Corp. shifting toward organic growth following a series of IT acquisitions makes the total equity history a key indicator of resource management efficiency, where a reverse calculation via ROA allows for precise tracking of the dynamics of all controlled assets and liabilities, helping investors assess the real cost of capital and the risk of its excessive concentration during the integration of acquired technologies.